Evidence map›Paper›PMID 37127804›Full record

Observational studyArchives of osteoporosis2023

Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study.

Yasser El Miedany, Maha El Gaafary, Naglaa Gadallah, Safaa Mahran, Nihal Fathi, Mohamed Hassan Abu Zaid, Samar Abdel Hamid Tabra, Waleed Hassan, Walaa Elwakil

Abstract readObservational StudyMulticenter Study
PubMed Publisher
In one paragraph

Observational study in Archives of osteoporosis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Yasser El MiedanyInstitute of Medical Sciences, Canterbury Christ Church University, Canterbury, England. yasserelmiedany@gmail.com.ORCID https://orcid.org/0000-0002-4543-692X
Maha El GaafaryCommunity and Public Health, Ain Shams University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-3948-3826
Naglaa GadallahRheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt.
Safaa MahranRheumatology and Rehabilitation, Assiut University, Assiut, Egypt.ORCID https://orcid.org/0000-0001-6446-9033
Nihal FathiRheumatology and Rehabilitation, Assiut University, Assiut, Egypt.
Mohamed Hassan Abu ZaidRheumatology and Rehabilitation, Tanta University, Tanta, Egypt.ORCID https://orcid.org/0000-0001-8436-8598
Samar Abdel Hamid TabraRheumatology and Rehabilitation, Tanta University, Tanta, Egypt.ORCID https://orcid.org/0000-0001-6414-5602
Waleed HassanRheumatology and Rehabilitation, Benha University, Benha, Egypt.ORCID https://orcid.org/0000-0002-3238-6804
Walaa ElwakilRheumatology, Physcial Medicine and Rehabilitation, Alexandria University, Alexandria, Egypt.ORCID https://orcid.org/0000-0001-8480-5698
Ain Shams University · EGAssiut University · EGTanta University · EGAlexandria University · EGBenha University · EGCanterbury Christ Church University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the wide availability of a wide variety of approved osteoporosis medications and DXA scan centers in Egypt, only a minority of patients at high risk of sustaining a fragility fracture receive treatment, even after their first fracture. Such big "treatment gap" leaves the most high-risk individuals unprotected against fragility fractures. This study provides a benchmark to monitor national trends in osteoporosis management and service uptake. PURPOSE: To assess the treatment gap among men and postmenopausal women presenting with a fragility fracture, and to analyze the characteristics and fracture risks of the patients presenting with an index fragility fracture.

methodsThis was a multi-center, cross-sectional, observational study. Both men and postmenopausal women, admitted with an osteoporotic fracture (whether major osteoporosis or hip fracture), were consecutively recruited for this work. The fracture risk was assessed based on their FRAX calculation prior to the index fracture. All the patients were assessed for their falls and sarcopenia risks. Blood tests for bone profile as well as DXA scan were offered to all the patients.

resultsTwo hundred and thirty-six patients presenting with fragility fractures were included in this work. 70.8% were women and 29.2% were men. Mean age was 70.1 (SD = 9.2) years. Ten-year probability of fracture (without BMD) was high in 65.9% of the postmenopausal women and 40.3% of the men. 82.1% of the postmenopausal women and 100% in men identified to be eligible for osteoporosis therapy did not receive any form of osteoporosis therapy. FRAX score correlated significantly with bone mineral density assessment at both hip and spine. Falls, sarcopenia, and functional disability showed significant relation to the fracture risk.

conclusionsThere is a large treatment gap in Egyptian older adults. The recent guidelines for osteoporosis management in Egypt endorsed fracture centric approach to identify people at risk. The gap appears to be related to a low rate of osteoporosis diagnosis and lack of patient education.

Indexed as

OsteoporosisOsteoporotic FracturesSarcopeniaAgedBone DensityCross-Sectional StudiesEgyptFemaleHumansMaleRisk AssessmentRisk FactorsEgyptian Academy of Bone HealthFallsImminent fractureOsteoporosisRiskSarcopeniaTreatment gap

Identifiers

PMID37127804
OpenAlexW4367597629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.